Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multi-Center, Open-Label Pharmacokinetic and Safety Study for Reduction in Fever or Management of Pain in Pediatric Subjects Aged Birth to Six Months

Next Previous
Trial Profile

A Multi-Center, Open-Label Pharmacokinetic and Safety Study for Reduction in Fever or Management of Pain in Pediatric Subjects Aged Birth to Six Months

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 29 Jun 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ibuprofen (Primary)
  • Indications Fever; Pain; Postoperative pain
  • Focus Pharmacokinetics
  • Sponsors Cumberland Pharmaceuticals

    • Most Recent Events

    • 26 Jun 2023 According to a Cumberland Pharmaceuticals media release, the positive results from this study supported recent U.S. FDA approval of expanded labeling of Caldolor in infants 3 to 6 months of age.
    • 09 Jun 2023 Results evaluating the pharmacokinetics and safety in children 1-6 months of age, published in the Pediatric Drugs.
    • 17 Mar 2020 According to a Cumberland Pharmaceuticals media release, Next steps include finalizing the full study report for submission to the FDA and then determining whether an additional pediatric indication will be available
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top